BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38517350)

  • 21. Should Level V Be Routinely Dissected in N1b Papillary Thyroid Carcinoma?
    Kim SK; Park I; Hur N; Lee JH; Choe JH; Kim JH; Kim JS
    Thyroid; 2017 Feb; 27(2):253-260. PubMed ID: 27762727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.
    Tunca F; Sormaz IC; Iscan Y; Senyurek YG; Terzioglu T
    J Endocrinol Invest; 2015 Dec; 38(12):1327-34. PubMed ID: 26280320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram.
    Wu SS; Joshi N; Sharrett J; Rao S; Shah A; Scharpf J; Burkey B; Lamarre ED; Prendes B; Siperstein A; Shin J; Berber E; Jin J; Krishnamurthi V; Nasr C; Hong L; Buchberger DS; Woody N; Koyfman SA; Geiger JL
    JAMA Otolaryngol Head Neck Surg; 2023 Jan; 149(1):79-86. PubMed ID: 36454559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
    Zhao H; Huang T; Li H
    Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence following hemithyroidectomy in patients with low- and intermediate-risk papillary thyroid carcinoma.
    Ahn D; Lee GJ; Sohn JH
    Br J Surg; 2020 May; 107(6):687-694. PubMed ID: 32026467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma.
    Raffaelli M; De Crea C; Sessa L; Tempera SE; Belluzzi A; Lombardi CP; Bellantone R
    Endocrine; 2019 Feb; 63(2):310-315. PubMed ID: 30341706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma.
    Lee SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg; 2019 May; 269(5):966-971. PubMed ID: 29462007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifocality Is not an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score-Matching Analysis.
    Geron Y; Benbassat C; Shteinshneider M; Or K; Markus E; Hirsch D; Levy S; Ziv-Baran T; Muallem-Kalmovich L
    Thyroid; 2019 Apr; 29(4):513-522. PubMed ID: 30799769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
    Nam SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2018 Jan; 28(1):88-95. PubMed ID: 29117854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-Varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up.
    Dong W; Horiuchi K; Tokumitsu H; Sakamoto A; Noguchi E; Ueda Y; Okamoto T
    Thyroid; 2019 Jun; 29(6):802-808. PubMed ID: 30931815
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term outcomes of lobectomy for papillary thyroid carcinoma with high-risk features.
    Xu S; Huang H; Wang X; Liu S; Xu Z; Liu J
    Br J Surg; 2021 Apr; 108(4):395-402. PubMed ID: 33793787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
    Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
    Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.
    Xia Q; Dong S; Bian PD; Wang J; Li CJ
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1037-43. PubMed ID: 25744048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma?
    Harries V; Wang LY; McGill M; Xu B; Tuttle RM; Wong RJ; Shaha AR; Shah JP; Ghossein R; Patel SG; Ganly I
    Surgery; 2020 Jan; 167(1):10-17. PubMed ID: 31515125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.
    Ji YB; Song CM; Kim D; Sung ES; Lee DW; Chung MS; Tae K
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3435-3442. PubMed ID: 31414221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of Neck Reoperation and Mortality After Initial Total Thyroidectomy for Differentiated Thyroid Cancer.
    Semrad TJ; Keegan THM; Semrad A; Brunson A; Farwell DG
    Thyroid; 2018 Sep; 28(9):1143-1152. PubMed ID: 29929451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Diagnostic Dilemma: Skip Metastasis in Papillary Thyroid Cancer.
    Özden S; Çomçalı B; Ataş H; Er S; Tez M; Saylam B
    Am Surg; 2020 Mar; 86(3):245-249. PubMed ID: 32223805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases.
    O'Neill CJ; Coorough N; Lee JC; Clements J; Delbridge LW; Sippel R; Sywak MS; Chen H; Sidhu SB
    ANZ J Surg; 2014 Apr; 84(4):240-4. PubMed ID: 23316684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.